Form 8-K - Current report:
SEC Accession No. 0001104659-22-121017
Filing Date
2022-11-22
Accepted
2022-11-22 08:42:49
Documents
13
Period of Report
2022-11-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2231102d1_8k.htm   iXBRL 8-K 32346
2 EXHIBIT 3.1 tm2231102d1_ex3-1.htm EX-3.1 310849
  Complete submission text file 0001104659-22-121017.txt   602637

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snpx-20221121.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20221121_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20221121_pre.xml EX-101.PRE 22599
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2231102d1_8k_htm.xml XML 3838
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 221407655
SIC: 2834 Pharmaceutical Preparations